# Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study

> **NCT02294643** · PHASE3 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 220 (actual)

## Conditions studied

- Coronary Artery Disease
- Diabetes Mellitus
- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Sarpogrelate
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel
- **DRUG:** Placebo (for Sarpogrelate)

## Key facts

- **NCT ID:** NCT02294643
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-03
- **Final completion:** 2014-03
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2014-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294643, "Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02294643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*